Table 2. Baseline characteristics.

Characteristic	Number subjects, N [%]
Age in years, median [range]	61 [40–78]
Gender
Male	19 [48]
Female	21 [53]
Race
Asian	1 [3]
Black or African American	2 [5]
White	31 [78]
Other	3 [8]
Unknown	3 [8]
ECOG PS
0	10 [25]
1	28 [70]
2	2 [5]
Received prior chemotherapy
Yes	29 [72.5]
No	11 [27.5]
Stage
Locally advanced	2 [5]
Metastatic	38 [95]
CA 19-9 (U/mL); median (range)	1,009 (3–678,332)
Number of metastatic sites, median (range)	2 (0–4)